SCHEMBL19639347

SCHEMBL19639347

CC(C)(C)OC(=O)/N=C(\NCc1ccc(NC(=O)c2ccccc2)cc1)NC(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.52
HDAC1 Q13547 4/20 0.51
PPARA Q07869 1/20 0.47
NR1H2 P55055 1/20 0.46
HDAC6 Q9UBN7 1/20 0.45
MAPT P10636 4/20 0.45
TDP1 Q9NUW8 4/20 0.45
KDM4E B2RXH2 3/20 0.45
PTPN1 P18031 1/20 0.44
MAPK1 P28482 1/20 0.44
ITGB3 P05106 1/20 0.44
ITGB1 P05556 1/20 0.44
ITGAV P06756 1/20 0.44
ITGA2B P08514 1/20 0.44
ITGB5 P18084 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPC1 O15118 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19639298 0.93 NR1H2 (0.49) NAMPTHDAC1PPARANR1H2HDAC6
SCHEMBL24892040 0.91 NAMPT (0.51) NAMPTHDAC1HDAC6MAPTTDP1
SCHEMBL19639348 0.89 SENP1 (0.49) NAMPTHDAC1MAPTSMN1; SMN2KMT2A
SCHEMBL24892290 0.88 NR1H4 (0.49) NAMPTHDAC1HDAC6MAPTTDP1
SCHEMBL17902822 0.86 CA1 (0.51) NAMPTHDAC1SMN1; SMN2MEN1KMT2A
SCHEMBL19651943 0.86 CA1 (0.51) NAMPTHDAC1SMN1; SMN2MEN1KMT2A
SCHEMBL24891756 0.85 NAMPT (0.46) NAMPTHDAC1HDAC6MAPTTDP1
SCHEMBL30182650 0.85 NAMPT (0.46) NAMPTHDAC1HDAC6MAPTTDP1
SCHEMBL24892259 0.83 NAMPT (0.44) NAMPTHDAC1HDAC6MAPTTDP1
SCHEMBL30182506 0.83 NAMPT (0.44) NAMPTHDAC1HDAC6MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170342025-A1 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS THE UNIVERSITY OF BATH (GB) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170342025-A1 ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS ZYX, MPO, CFB NAMPT 2070/4885HDAC1 1517/4885PPARA 1664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.